Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine vs Entecavir in HBeAg-positive Chronic Hepatitis B (TERESA)
NCT01595685Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- May 2012
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Asan Medical Center. Started May 2012; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01595685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595685.